Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
8035 Quivira Road, Lenexa, KS, 66214, US
With over 40 years of experience, we provide a seamless, solutions-based approach for safety, bioanalytical, and specialty testing, as well as clinical trial IMP supplies, in support of phase I to IV clinical trials. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies around the world.
Plans an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in Gaithersburg.
By: Charlie Sternberg
Sentry’s foreign trade zone expertise helps pharmaceutical companies mitigate risks from tariffs and global trade volatility.
Released By Sentry BioPharma Services, Inc.
AGC Biologics to provide GMP manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss.
A conversation with Upperton’s Director of Pharmaceutical Sciences
Released By Upperton
To provide access to dedicated, fully equipped wet lab facilities and strategic scientific engagement.
By: Kristin Brooks
Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL).
Marks a strategic milestone in Halozyme’s mission to expand its drug delivery technology offerings to biopharma companies.
Strengthens its peptide technology platform to meet the rapidly growing global demand for peptide-based therapeutics.
Expands the company’s nationwide network supporting cell and gene therapy (CGT) innovation.
New program is designed to provide financial support to Japanese academic research with the goal of accelerating the translation of innovation into novel therapies for patients.
Non-exclusive license provides Solid’s proprietary, next-gen capsid, AAV-SLB101, to Andelyn Biosciences.
Merus has licensed Halozyme's ENHANZE drug delivery technology for the development and potential commercialization of subcutaneous administration of petosemtamab.
Tyruko (natalizumab) is the first and only biosimilar for Multiple Sclerosis.
By: Rachel Klemovitch
Revenue in the quarter was impacted by declines in COVID-19 product sales.
Over the past 20 years, the company has grown from a small startup into a trusted CDMO partner for biopharma companies worldwide.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
